妇科相关静脉血栓栓塞症的风险评估流程和临床实践管理

doi:10.12114/j.issn.1007-9572.2018.00.345

摘要/Abstract

摘要： 随着社会老龄化的加重和肥胖人群的增加，静脉血栓栓塞症（VTE）的发生率不断增高。VTE已成为妇科疾病治疗过程中危及患者生命的严重合并症，但同时也是临床上可以有效预防的疾病。科学的风险评估、合理的预防措施及对VTE疾病严重程度的危险分层，有助于降低妇科VTE的发生率和病死率。本文依据现有循证医学证据，参考相关学科指南和专家意见，结合日常的工作实践，总结出妇科相关VTE的风险评估流程和临床实践方法，便于全科医生和妇科临床医生对VTE风险进行快速评估和制定正确的治疗决策。静脉血栓栓塞；风险评估；指南；诊断；治疗；妇科学 10.12114/j.issn.1007-9572.2018.00.345

Abstract: As the aging of society and the increasing prevalence of obesity，the incidence rate of venous thromboembolism（VTE） is growing.Although VTE has become a serious complication that threatens the safety of patients during the treatment of gynecological diseases，it can be prevented clinically by effective ways.Scientific risk assessment，reasonable preventive measures，and risk stratification of the severity of VTE disease can help reduce the incidence rate of and mortality from VTE in gynecologic patients.Based on the existing evidence-based studies in combination with relevant subject guidelines and expert opinions，as well as our daily clinical practices，we summarized the risk assessment process and clinical practice for VTE in gynecologic patients，aiming to help general practitioner and gynaecologists quickly assess VTE risk and make correct treatment decisions.

Key words: Venous thromboembolism, Risk assessment, Guidebooks, Diagnosis, Therapy, Gynecology

高红,王建东,佟彤. 妇科相关静脉血栓栓塞症的风险评估流程和临床实践管理[J]. 中国全科医学, 2019, 22(12): 1385-1391. DOI: 10.12114/j.issn.1007-9572.2018.00.345.
GAO Hong,WANG Jiandong,TONG Tong. Risk Assessment Procedures and Management of Clinical Practice for Venous Thromboembolism in Gynecologic Patients　[J]. Chinese General Practice, 2019, 22(12): 1385-1391. DOI: 10.12114/j.issn.1007-9572.2018.00.345.

参考文献

［1］HILL J，TREASURE T.Reducing the risk of venous thromboembolism in patients admitted to hospital：summary of NICE guidance［J］．BMJ，2010，27（340）：c95．DOI：10.1136/bmj.c95.
［2］FALCK-YTTER Y，FRANCIS C W，JOHANSON N A.Prevention of VTE in orthopedic surgery patients：Antithrombotic Therapy and Prevention of Thrombosis，9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines［J］．Chest，2012，141（2 Suppl）：e278S-325．DOI：10.1378/chest.11-2404.
［3］Committee on Practice Bulletins-Gynecology，American College of Obstetricians and Gynecologists.ACOG Practice Bulletin No.84：Prevention of deep vein thrombosis and pulmonary embolism［J］．Obstet Gynecol，2007，110（2 Pt 1）：429-440．DOI：10.1097/01.AOG.0000263919.23437.15.
［4］刘玉珍，张震宇，郭淑丽，等．妇科盆腔手术后下肢深静脉血栓形成的临床研究［J］．中华妇产科杂志，2006，41（2）：107-110．DOI：10.3760/j.issn：0529-567X.2006.02.010.
［5］QU H，LI Z，ZHAI Z，et al．Predicting of venous thromboembolism for patient undergoing gynecological surgery［J］．Medicine （Baltimore），2015，94（39）：e1653．DOI：10.1097/MD.0000000000001653.
［6］MARTINO M A，WILLIAMSON E，SIEGFRIED S，et al．Diagnosing pulmonary embolism：experience with spiral CT pulmonary angiography in gynecologic oncology［J］．Gynecol Oncol，2005，98（2）：289-293．DOI：10.1016/j.ygyno.2005.04.020.
［7］中国临床肿瘤学会（CSCO）肿瘤与血栓专家共识委员会.肿瘤相关静脉血栓栓塞症的预防与治疗中国专家指南（2015版）［J］．中国肿瘤临床，2015，42（20）：979-991．DOI：10.3969/j.issn.1000-8179.2015.20.015.
［8］Committee on Gynecologic Practice.ACOG Committee Opinion Number 540：risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills［J］．Obstet Gynecol，2012，120（5）：1239-1242．DOI：http：//10.1097/AOG.0b013e318277c93b.
［9］中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南（第三版）［J］．中华普通外科杂志，2017，32（9）：807-812．DOI：10.3760/cma.j.issn.1007-631X.2017.09.032.
［10］Practice Bulletin No.84：Prevention of deep vein thrombosis and pulmonary embolism：correction［J］．Obstet Gynecol，2016，127（1）：166．DOI：10.1097/AOG.0000000000001229.
［11］CAPRINI J A.Risk assessment as a guide for the prevention of the many faces of venous thromboembolism［J］．Am J Surg，2010，199（1 Suppl）：S3-10．DOI：10.1016/j.amjsurg.2009.10.006.
［12］郎景和，王辰，瞿红，等．妇科手术后深静脉血栓形成及肺栓塞预防专家共识［J］．中华妇产科杂志，2017，52（10）：649-653．DOI：10.3760/cma.j.issn.0529-567x.2017.10.001.
LANG J H，WANG C，QU H，et al．Expert consensus on prevention of deep vein thrombosis and pulmonary embolism after gynecological surgery［J］．Chin J Obstet Gynecol，2017，52（10）：649-653．DOI：10.3760/cma.j.issn.0529-567x.2017.10.001.
［13］赵宇驰，王诗军，孔刚，等．糖尿病与静脉血栓栓塞症［J］．中华关节外科杂志（电子版），2013，7（3）：81-82．DOI：10.3877/cma.j.issn.1674-134X.2013.03.024.
［14］邸平，梁臻龙，徐丽娟，等．静脉血栓栓塞症患者及脑梗塞患者易栓因素研究［J］．血栓与止血学，2016，22 （6）：630-632．DOI：10.3969/j.issn.1009-6213.2016.06.010.
［15］GOULD M K，GARCIA D A，WREN S M，et al．Prevention of VTE in nonorthopedic surgical patients：Antithrombotic Therapy and Prevention of Thrombosis，9th ed：American College of Chest Physicians Evidence-Based Clinical Practice Guidelines［J］．Chest，2012，141（2 Suppl）：e227S-277．DOI：10.1378/chest.11-2297.
［16］中华医学会外科学分会.中国普通外科围术期血栓预防与管理指南［J］．中华外科杂志，2016，54（5）：321-327．DOI：10.3760/cma.j.issn.0529-5815.2016.05.001.
［17］KHORANA A A，KUDERER N M，CULAKOVA E，et al．Development and validation of a predictive model for chemotherapy-associated thrombosis［J］．Blood，2008，111（10）：4902-4907．DOI：10.1182/blood-2007-10-116327.
［18］KHORANA A A，FRANCIS C W，CULAKOVA E，et al．Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study［J］．Cancer，2005，104（12）：2822-2829．DOI：10.1002/cncr.21496.
［19］LYMAN G H，KHORANA A A，KUDERER N M，et al．Venous thromboembolism prophylaxis and treatment in patients with cancer：American society of clinical oncology clinical practice guideline update［J］．J Clin Oncol，2013，31（17）：2189-2204．DOI：10.1200/JCO.2013.49.1118.
［20］CURB J D，PRENTICE R L，BRAY P F，et al．Venous thrombosis and conjugated equine estrogen in women without a uterus［J］．Arch Intern Med，2006，166（7）：772-780．DOI：10.1001/archinte.166.7.772.
［21］CUSHMAN M，KULLER L H，PRENTICE R，et al．Estrogen plus progestin and risk of venous thrombosis.Women's Health Initiative Investigators［J］．JAMA，2004，292（13）：1573-1580．DOI：10.1001/jama.292.13.1573.
［22］STRACZEK C，OQER E，JONAGE-CANONICO M B，et al．
Prothrombotic mutations，hormone therapy，and venous thromboembolism among postmenopausal women：impact of the route of estrogen administration［J］．Circulation，2005，112（22）：3495-3500．DOI：10.1161/CIRCULATIONAHA.105.565556.
［23］KNOWLSON L，BACCHU S，PANEESHA S，et al．Elevated D-dimers are also a marker of underlying malignancy and increased mortality in the absence of venous thromboembolism［J］．J Clin Pathol，2010，63（9）：818-822．DOI：10.1136/jcp.2010.076349.
［24］KONSTANTINIDES S V.2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism［J］．Eur Heart J，2014，35（45）：3145-3146．DOI：10.1093/eurheartj/ehu393.
［25］中华医学会心血管病学分会肺血管病学组.急性肺栓塞诊断与治疗中国专家共识（2015）［J］．中华心血管病杂志，2016，44（3）：197-211．DOI：10.3760/cma.j.issn.0253-3758.2016.03.005.
［26］KEARON C，AKI E A，ORNELAS J，et al．Antithrombotic therapy for VTE disease：CHEST Guideline and Expert Panel Report［J］．Chest，2016，149 （2）：315-352．DOI：10.1016/j.chest.2015.11.026.